Objectives: The study aimed to evaluate cost trends associated with mitral valve transcatheter edge-to-edge repair (TEER).
Background: TEER is a treatment option for patients at prohibitive surgical risk with moderate to severe mitral valve regurgitation and NYHA class III or IV symptoms. The 30-day costs and causes of readmission following TEER have not been well studied.
Background: KCNJ2 mutations are associated with a variety of inherited arrhythmia syndromes including catecholaminergic polymorphic ventricular tachycardia 3.
Objective: To characterize the detailed cellular mechanisms of the clinically recognized KCNJ2 mutation R67Q.
Methods: Kir2.